2018. A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S29. DOI:https://doi.org/10.25251/skin.2.supp.28.